Healthcare — The Stock Radio

Home » Healthcare

Jason Price Chairman & CEO of Avvaa World Health Care Products, Inc. (OTCPINK-AVVH)

May 6, 2013 / Healthcare, Uncategorized

. . . AvVaa World Health Care Products, Inc., a biotechnology company, provides natural and therapeutic skin care products worldwide. The company primarily focuses on manufacturing and marketing over-the-counter the Neuroskin line of products used for the treatment of skin abnormalities, and to enhance the natural clarity and texture of healthy skin through mass marketing food and drug channels. It also has distribution rights for patented European skin care products, which are scientifically developed to treat the symptoms of skin [...]

Continue reading »
Pres & CEO Mark Emalfarb of DYADIC INTERNATIONAL IND (DYAI.PK)

April 29, 2013 / Healthcare

. . . Dyadic International, Inc. is a global biotechnology company headquartered in Jupiter, Florida with operations in the United States and the Netherlands. Dyadic uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzymes and others proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries

Continue reading »
Pres & CEO: John McManus of AEOLUS PHARMACETICALS INC (AOLS-OTCQB)

April 23, 2013 / Healthcare

. . . Aeolus Pharmaceuticals, Inc., a biotechnology company, engages in the development of a platform of novel compounds that protect against radiological and chemical threats and for use in oncology. The company develops a class of catalytic antioxidant compounds as a medical countermeasure against biological, chemical, and radiological weapons, as well as for diseases and disorders of the central nervous system, respiratory system, autoimmune system, and oncology. Its lead compound, AEOL 10150, which completed 2 Phase I clinical trials [...]

Continue reading »
CEO & President, of Atossa Genetics, Inc (ATOS.NASDAQ)

January 28, 2013 / Healthcare

. . . Atossa Genetics, Inc. operates as a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States. Its diagnostic tests include the ForeCYTE Breast Health Test, which provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65; and the ArgusCYTE Breast Health Test that offers information to help inform breast cancer treatment options and to [...]

Continue reading »
CFO Steven Borst of Q Therapeutics (QCEL)

December 25, 2012 / Healthcare, Technology

. . . About Q Therapeutics, Inc. Headquartered in Salt Lake City, Utah, Q Therapeutics, Inc. is a fully reporting, non-trading company, engaged in developing adult stem cell therapies to treat debilitating diseases of the central nervous system. The Company’s first product, Q-Cells®, is a cell-based therapeutic intended to restore or preserve normal activity of neurons by providing essential support functions that occur in healthy central nervous system tissues. Q-Cells may be applicable to a wide range of central nervous [...]

Continue reading »
David Cunic CEO of PAZOO Inc (OTCQB-PZOO)

November 30, 2012 / Healthcare

. . . Health and wellness online warehouse for people and their pets providing not only products and services but also an expert section providing a forum for indivuals to seek and find out information for the betterment of their health and wellness. discount cialis online

Continue reading »
Pres & CEO: DR Robert Ryan of Nuvilex Inc (OTC:NVLX)

November 15, 2012 / Healthcare, Technology

. . . Nuvilex, Inc, is a highly innovative biotechnology and life technology company developing treatments for a number of diseases through a unique and proprietary live cell encapsulation process. The Company is engaged in the development and marketing of products for enhancing the health and well-being of people worldwide. Living cell encapsulation technology, or the Cell-in-a-Box® technology, enables living cells to be used as a miniature factory in which cells can be grown and maintained or desired components can [...]

Continue reading »
President, CEO Cameron Reynolds of VolitionRX Ltd (OTC:VNRX)

November 12, 2012 / Healthcare, Technology

. . . VolitionRX is a life sciences company whose goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats. VolitionRX is managed by a well-respected team with extensive experience in diagnostics and commercialization. Volition’s development activities are currently centered in Belgium and will be augmented by commercialization work in Singapore with a focus on bringing its revolutionary diagnostic products to market first in Europe, [...]

Continue reading »
Chief Medical Officer Dr Kenneth Snow MBA of NeuroMetrix Inc (NURO:Nasdaq)

October 29, 2012 / Healthcare, Technology, Uncategorized

. . . NeuroMetrix, Inc., a science-based health care company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with diabetes, carpal tunnel syndrome, lumbosacral disc disease, and spinal stenosis. The company focuses on the diagnosis and treatment of neurological complications of diabetes, including diabetic peripheral neuropathy (DPN) and median neuropathy. Its marketed products include the ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction [...]

Continue reading »

The Stock Radio ("TSR") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of TSR may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. TSR, the authors, the publisher, and all affiliates of TSR assume no responsibility or liability for your trading and investment results. Factual statements on the TSR's website, or in its publications, are made as of the date stated and are subject to change without notice. For TSR full disclaimer and disclosure go to our disclaimer page. It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by TSR are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of TSR's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on TSR's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.